Type of security: Stock
Sector: Health Care
Industry: Medical/Dental Instruments
The data is delayed by 15 minutes.
Description: Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. It offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary technology products used to treat patients with atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. The company also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters to treat patients with peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat patients with non-vascular disease. In addition, it offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and tr
|Shares Outstanding||EPS||0.73||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||-5.61%||Sales Growth - Q/Q||-6.31%||P/E||38.01|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-1.54%||ROE||-3.89%||ROI||-1.94%|
|Current Ratio||1.29||Quick Ratio||0.91||Long Term Debt/Equity||5.3||Debt Ratio||0.38|
|Gross Margin||70.26%||Operating Margin||-6.43%||Net Profit Margin||-3.43%||Dividend Payout Ratio|
|Cash From Financing Activities||-94 M||Cash From Investing Activities||-51 M||Cash From Operating Activities||-197 M||Gross Profit||1.3 B|
|Net Profit||102 M||Operating Profit||219 M||Total Assets||17.12 B||Total Current Assets||3.77 B|
|Total Current Liabilities||1.94 B||Total Debt||5.11 B||Total Liabilities||10.54 B||Total Revenue||1.84 B|
|High 52 week||43.45||Low 52 week||31.73||Last close||38.46||Last change||1.29%|
|RSI||32.22||Average true range||1.16||Beta||0.9||Volume||4.25 M|
|Simple moving average 20 days||-4.97%||Simple moving average 50 days||-7.45%||Simple moving average 200 days||-2.99%|
|Performance Week||1.56%||Performance Month||-8.3%||Performance Quart||-8.95%||Performance Half||6.33%|
|Performance Year||3.97%||Performance Year-to-date||8.83%||Volatility daily||2.11%||Volatility weekly||4.71%|
|Volatility monthly||9.65%||Volatility yearly||33.42%||Relative Volume||246.39%||Average Volume||6.14 M|
|New High||New Low|
2019-11-16 15:54:35 | UPDATE 1-Stents no better than drugs for many heart patients -U.S. study
2019-11-16 14:00:00 | Stents no better than drugs for many heart patients -U.S. study
2019-11-13 13:50:39 | Large Option Traders Betting Boston Scientific Has Run Out Of Steam
2019-11-10 08:00:24 | How Good Is Boston Scientific Corporation NYSE:BSX, When It Comes To ROE?
2019-11-08 12:15:00 | 78 Stocks in the S&P 500 Don’t Pay a Dividend. Here Are Some That Should.
2019-11-06 18:30:00 | Boston Scientific Prices €900,000,000 of Senior Notes
2019-11-05 11:01:55 | Which Companies Recently Raised Guidance?
2019-11-01 09:30:00 | Boston Scientific Announces November 2019 Conference Schedule
2019-10-24 09:47:01 | Boston Scientific BSX Catches Eye: Stock Jumps 5%
2019-10-24 09:31:01 | Company News For Oct 24, 2019
2019-10-23 22:45:14 | Edited Transcript of BSX earnings conference call or presentation 23-Oct-19 12:00pm GMT
2019-10-23 16:04:04 | These Medtech Giants Are Nearing Breakouts After Earnings 'Crushed' It
2019-10-23 13:02:00 | Boeing, Caterpillar report disappointing earnings, but their shares bounce back
2019-10-23 10:37:00 | Boston Scientific Stock Gains on Strong Earnings
2019-10-23 09:49:01 | Boston Scientific BSX Beats on Q3 Earnings, Tapers EPS View
2019-10-23 09:10:00 | Boston Scientific Shares Rise on Third-Quarter Earnings Beat, Increased Guidance
2019-10-23 07:45:11 | Boston Scientific BSX Q3 Earnings and Revenues Beat Estimates
2019-10-23 06:58:00 | Boston Scientific's stock surges after profit and sales rise, beat expectations
2019-10-23 06:30:00 | Boston Scientific Announces Results For Third Quarter 2019
2019-10-22 14:49:00 | [video]Boston Scientific Expected to Earn 38 Cents a Share
2019-10-22 11:25:03 | Medical Products' Earnings Roster for Oct 23: TMO, BSX & More
2019-10-22 09:13:01 | Medical Products Industry Outlook: Prospects Seem Promising
2019-10-21 11:35:03 | Can Overall Growth Boost Boston Scientific BSX Q3 Earnings?
2019-10-18 07:03:18 | Is Boston Scientific's NYSE:BSX Share Price Gain Of 200% Well Earned?
2019-10-16 10:32:02 | Boston Scientific BSX Earnings Expected to Grow: Should You Buy?
2019-10-15 20:43:16 | Newton-Wellesley Hospital CEO steps down to join Boston Scientific
2019-10-09 10:36:55 | Hedge Funds Have Never Been This Bullish On Boston Scientific Corporation BSX
2019-10-02 09:48:01 | Abbott ABT Gets FDA Nod for New Troponin-I Blood Test
2019-10-02 09:25:01 | Abiomed's ABMD Impella 5.5 With SmartAssist Gets FDA Nod
2019-10-02 09:23:01 | Medtronic Upbeat on Drug-Eluting Stents in Patients With DAPT
2019-10-01 09:30:01 | PETQ vs. BSX: Which Stock Is the Better Value Option?
2019-09-30 08:59:12 | Boston Scientific BSX Upbeat on Results of EVOLVE Study
2019-09-29 10:59:29 | 8 'Low Beta' Growth Stocks That Can Lead Amid Market's Turmoil
2019-09-26 07:33:17 | 3 “Strong Buy” Med Tech Stocks Amid Recession Threat
2019-09-25 10:38:59 | Boston Scientific Corporation NYSE:BSX Insiders Have Been Selling
2019-09-19 09:35:00 | 10 Stable Growth Stocks That Are Still Worth the Price, According to an Analyst
2019-09-13 09:40:01 | BAX or BSX: Which Is the Better Value Stock Right Now?
2019-09-13 09:13:01 | IoMT Becomes the Buzzword in New Age MedTech Investing
2019-09-10 11:07:35 | Morgan Stanley: Buy These 3 Stocks on Recent Weakness
2019-09-10 07:13:25 | 3 Big Stock Charts for Tuesday: Boston Scientific, GM and United Airlines